Cargando…
Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancer cases. Recent advancements in diagnostic tools, surgical treatments, chemotherapies, and molecular targeted therapies that improved the therapeutic...
Autores principales: | Zhu, Xinping, Kudo, Masahisa, Huang, Xiangjie, Sui, Hehuan, Tian, Haishan, Croce, Carlo M., Cui, Ri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058364/ https://www.ncbi.nlm.nih.gov/pubmed/33898432 http://dx.doi.org/10.3389/fcell.2021.643942 |
Ejemplares similares
-
The MicroRNA Family Gets Wider: The IsomiRs Classification and Role
por: Tomasello, Luisa, et al.
Publicado: (2021) -
MicroRNA Signatures of the Developing Primate Fovea
por: Fishman, Elizabeth S., et al.
Publicado: (2021) -
microRNA Prognostic Signature for Postoperative Success of Metastatic Orthopedic Cancers: Implications for Precision Microsurgery
por: Xu, Shi-Bao, et al.
Publicado: (2021) -
Role of microRNA carried by small extracellular vesicles in urological tumors
por: Mao, Yiping, et al.
Publicado: (2023) -
MicroRNAs: Emerging players in the pathogenesis of vitiligo
por: Yu, Xin, et al.
Publicado: (2022)